STOCK TITAN
  1. Home
  2. Sec-filings
  3. NTRA
  4. [Form 4] Natera, Inc. Insider Trading Activity

[Form 4] Natera, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock NTRA logo
Natera Inc

NASDAQ:NTRA

NTRA Rankings

#774 Ranked by Market Cap
N/A Ranked by Dividends

NTRA Latest News

Jul 7, 2025
Natera Presents Data at ESMO GI on its Tissue-Free Latitude™ MRD* Assay, Demonstrating Excellent Overall Performance in Colorectal Cancer
Jul 1, 2025
Natera to Present Clinical and Economic Utility of Signatera at ESMO GI, Highlights Innovations in MRD
Jun 4, 2025
Natera Announces Medicare Coverage for Signatera™ Genome
Jun 2, 2025
SignateraTM Genome Clinical Performance Highlighted at ASCO 2025
May 22, 2025
Natera to Present over 25 Signatera™ Studies at 2025 ASCO Annual Meeting

NTRA Latest SEC Filings

Jul 3, 2025
[Form 4] Natera, Inc. Insider Trading Activity
Jul 3, 2025
[Form 4] Natera, Inc. Insider Trading Activity
Jul 3, 2025
[Form 4] Natera, Inc. Insider Trading Activity
Jul 3, 2025
[Form 4] Natera, Inc. Insider Trading Activity
Jul 1, 2025
[Form 4] Natera, Inc. Insider Trading Activity

NTRA Stock Data

22.31B
131.58M
3.45%
93.67%
2.13%
Diagnostics & Research
Services-medical Laboratories
Link
United States
AUSTIN